S&P ASX All Technology

3,087.60

-0.48%

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Curagen Corp. (MM) (CRGN)
Curagen Corp. (MM) (CRGN) News

CRGN

Curagen Corp. (MM) (CRGN)

Curagen Corp. (MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CRGN

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
02/10/2009	20:02	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CRGN	Curagen Corp. (MM)
02/10/2009	06:28	Edgar (US Regulatory)	(25-NSE)	NASDAQ:CRGN	Curagen Corp. (MM)
02/10/2009	04:29	Business Wire	Celldex Therapeutics Announces Completed Acquisition of CuraGen Corporation	NASDAQ:CRGN	Curagen Corp. (MM)
01/10/2009	08:00	Business Wire	Celldex and CuraGen Stockholders Approve Acquisition of CuraGen Corporation	NASDAQ:CRGN	Curagen Corp. (MM)
26/09/2009	06:33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRGN	Curagen Corp. (MM)
26/09/2009	03:33	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CRGN	Curagen Corp. (MM)
03/09/2009	20:01	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:CRGN	Curagen Corp. (MM)
29/08/2009	07:27	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)	NASDAQ:CRGN	Curagen Corp. (MM)
18/08/2009	06:50	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/A)	NASDAQ:CRGN	Curagen Corp. (MM)
11/08/2009	01:59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRGN	Curagen Corp. (MM)
06/08/2009	04:03	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:CRGN	Curagen Corp. (MM)
01/08/2009	04:35	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CRGN	Curagen Corp. (MM)
01/08/2009	04:33	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:CRGN	Curagen Corp. (MM)
31/07/2009	20:00	PR Newswire (US)	CuraGen Reports Second Quarter 2009 Financial Results	NASDAQ:CRGN
23/06/2009	07:07	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:CRGN	Curagen Corp. (MM)
20/06/2009	03:45	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	NASDAQ:CRGN	Curagen Corp. (MM)
19/06/2009	03:43	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CRGN	Curagen Corp. (MM)
17/06/2009	20:30	PR Newswire (US)	CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer	NASDAQ:CRGN	Curagen Corp. (MM)
11/06/2009	07:02	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:CRGN	Curagen Corp. (MM)
10/06/2009	05:22	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	NASDAQ:CRGN	Curagen Corp. (MM)
04/06/2009	05:42	Edgar (US Regulatory)	Amended Current report filing (8-K/A)	NASDAQ:CRGN	Curagen Corp. (MM)
02/06/2009	20:30	PR Newswire (US)	CuraGen Updates CR011-vcMMAE Data at ASCO	NASDAQ:CRGN	Curagen Corp. (MM)
30/05/2009	07:26	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CRGN	Curagen Corp. (MM)
30/05/2009	07:24	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:CRGN	Curagen Corp. (MM)
30/05/2009	06:50	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:CRGN	Curagen Corp. (MM)
30/05/2009	06:35	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CRGN	Curagen Corp. (MM)
30/05/2009	06:33	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:CRGN	Curagen Corp. (MM)
29/05/2009	20:54	Business Wire	Celldex Therapeutics, Inc. Enhances Precision Targeted Immunotherapy Platform with the Acquisition of CuraGen Corporation	NASDAQ:CRGN	Curagen Corp. (MM)
28/05/2009	20:30	PR Newswire (US)	CuraGen to Present CR011-vcMMAE Data at ASCO	NASDAQ:CRGN	Curagen Corp. (MM)
20/05/2009	05:15	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	NASDAQ:CRGN	Curagen Corp. (MM)